2012
Psoriasis
Sponsor: Amgen
Etanercept Treatment in Patients With Moderate to Severe Plaque Psoriasis Who Lost Response to Adalimumab
Phase: Phase 4
Start Date: February 2012
End Date: May 2015
Actinic Keratosis
Sponsor: LEO Pharma
A Sequential Treatment Regimen of Cryotherapy and Picato® for the Treatment of Actinic Keratosis on the Face and Scalp
Phase: Phase 3
Start Date: March 2012
End Date: July 2013
Psoriasis Vulgaris
Sponsor: LEO Pharma
LEO 90100 Compared With Calcipotriol Plus Betamethasone Dipropionate Ointment, LEO 90100 Vehicle and Ointment Vehicle in Subjects With Psoriasis Vulgaris
Phase: Phase 2
Start Date: May 2012
End Date: November 2012
Psoriasis Vulgaris
Sponsor: LEO Pharma
LEO 90100 in the Treatment of Psoriasis Vulgaris
Phase: Phase 2
Start Date: May 2012
End Date: November 2012
Psoriasis
Sponsor: Eli Lilly and Company
A Phase 3 Study in Participants With Moderate to Severe Psoriasis (UNCOVER-2)
Phase: Phase 3
Start Date: May 2012
End Date: July 2019
Actively Extending Plaque Psoriasis
Sponsor: Idera Pharmaceuticals, Inc.
Trial of IMO-3100 in Patients With Moderate to Severe Plaque Psoriasis
Phase: Phase 2
Start Date: May 2012
End Date: December 2012
Acne Vulgaris
Sponsor: Intrepid Therapeutics, Inc.
A Phase 2 Dose Escalating Study to Evaluate the Safety and Efficacy of CB-03-01 Cream in Subjects With Facial Acne Vulgaris
Phase: Phase 2
Start Date: June 2012
End Date: February 2014
Papulopustular Rosacea
Sponsor: Bayer
Safety and Efficacy of Azelaic Acid Foam, 15 % in Papulopustular Rosacea
Phase: Phase 3
Start Date: September 2012
End Date: January 2014
Actinic Keratosis
Sponsor: Teva Pharmaceuticals USA
Study Comparing Imiquimod Cream, 3.75% to Zyclara® (Imiquimod) Cream, 3.75% in the Treatment of Actinic Keratosis
Phase: Phase 3
Start Date: September 2012
End Date: August 2013